Ghent University Academic Bibliography

Advanced

The use of adalimumab for cricoarytenoid arthritis in ankylosing spondylitis: an effective therapy

Gauthier Desuter, Thierry Duprez, Caroline Huart, Quentin Gardiner and August Verbruggen UGent (2011) LARYNGOSCOPE. 121(2). p.335-338
abstract
This report describes cartilaginous regeneration in a cricoarytenoid joint affected by spondyloarthropathy using tumor necrosis factor-alpha (TNF-alpha) blockade, monitored by magnetic resonance (MR) and computed tomography (CT) imaging. This case is interesting for several reasons. It is only the eighth case of destructive ankylosing spondylitis-related cricoarytenoid arthritis published in the English language literature. It describes, for the first time, full recovery of vocal cord mobility following TNF-alpha blockade. It is also the first case to be published with MR imaging demonstrating regeneration of the cricoarytenoid cartilage following treatment. This case represents a landmark in the treatment of patients presenting with destructive arthritis involving the cricoarytenoid joint.
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle (original)
publication status
published
subject
keyword
RHEUMATOID-ARTHRITIS, JOINTS, Laryngology
journal title
LARYNGOSCOPE
Laryngoscope
volume
121
issue
2
pages
335 - 338
Web of Science type
Article
Web of Science id
000287006400019
JCR category
OTORHINOLARYNGOLOGY
JCR impact factor
1.752 (2011)
JCR rank
10/41 (2011)
JCR quartile
1 (2011)
ISSN
0023-852X
DOI
10.1002/lary.21343
language
English
UGent publication?
yes
classification
A1
copyright statement
I have transferred the copyright for this publication to the publisher
id
1975360
handle
http://hdl.handle.net/1854/LU-1975360
date created
2011-12-29 10:42:17
date last changed
2016-12-19 15:45:31
@article{1975360,
  abstract     = {This report describes cartilaginous regeneration in a cricoarytenoid joint affected by spondyloarthropathy using tumor necrosis factor-alpha (TNF-alpha) blockade, monitored by magnetic resonance (MR) and computed tomography (CT) imaging. This case is interesting for several reasons. It is only the eighth case of destructive ankylosing spondylitis-related cricoarytenoid arthritis published in the English language literature. It describes, for the first time, full recovery of vocal cord mobility following TNF-alpha blockade. It is also the first case to be published with MR imaging demonstrating regeneration of the cricoarytenoid cartilage following treatment. This case represents a landmark in the treatment of patients presenting with destructive arthritis involving the cricoarytenoid joint.},
  author       = {Desuter, Gauthier and Duprez, Thierry and Huart, Caroline and Gardiner, Quentin and Verbruggen, August},
  issn         = {0023-852X},
  journal      = {LARYNGOSCOPE},
  keyword      = {RHEUMATOID-ARTHRITIS,JOINTS,Laryngology},
  language     = {eng},
  number       = {2},
  pages        = {335--338},
  title        = {The use of adalimumab for cricoarytenoid arthritis in ankylosing spondylitis: an effective therapy},
  url          = {http://dx.doi.org/10.1002/lary.21343},
  volume       = {121},
  year         = {2011},
}

Chicago
Desuter, Gauthier, Thierry Duprez, Caroline Huart, Quentin Gardiner, and August Verbruggen. 2011. “The Use of Adalimumab for Cricoarytenoid Arthritis in Ankylosing Spondylitis: An Effective Therapy.” Laryngoscope 121 (2): 335–338.
APA
Desuter, G., Duprez, T., Huart, C., Gardiner, Q., & Verbruggen, A. (2011). The use of adalimumab for cricoarytenoid arthritis in ankylosing spondylitis: an effective therapy. LARYNGOSCOPE, 121(2), 335–338.
Vancouver
1.
Desuter G, Duprez T, Huart C, Gardiner Q, Verbruggen A. The use of adalimumab for cricoarytenoid arthritis in ankylosing spondylitis: an effective therapy. LARYNGOSCOPE. 2011;121(2):335–8.
MLA
Desuter, Gauthier, Thierry Duprez, Caroline Huart, et al. “The Use of Adalimumab for Cricoarytenoid Arthritis in Ankylosing Spondylitis: An Effective Therapy.” LARYNGOSCOPE 121.2 (2011): 335–338. Print.